Difference between revisions of "LncRNAWiki:E"
(Created page with "{|class="wikitable sortable" style="width:90%;text-align:center" |- !Name !Transcript ID !Alias !Description |- |''EGFR-AS1'' |EGFR-AS1 |N/A |EGFR antisense RNA 1 |- |''EG...") |
|||
| Line 1: | Line 1: | ||
| + | <div style="padding:0.2em 0.5em;text-align:right;font-size:125%;font-weight:bold;color:#2d2d2d;"> | ||
| + | Jump to section in alphabetical order : [[LncRNAWiki:A|'''A''']] [[LncRNAWiki:B|'''B''']] [[LncRNAWiki:C|'''C''']] [[LncRNAWiki:D|'''D''']] '''E''' [[LncRNAWiki:F|'''F''']] [[LncRNAWiki:G|'''G''']] [[LncRNAWiki:H|'''H''']] [[LncRNAWiki:I|'''I''']] [[LncRNAWiki:J|'''J''']] [[LncRNAWiki:K|'''K''']] [[LncRNAWiki:L|'''L''']] [[LncRNAWiki:M|'''M''']] [[LncRNAWiki:N|'''N''']] [[LncRNAWiki:O|'''O''']] [[LncRNAWiki:P|'''P''']] [[LncRNAWiki:R|'''R''']] [[LncRNAWiki:S|'''S''']] [[LncRNAWiki:T|'''T''']] [[LncRNAWiki:U|'''U''']] [[LncRNAWiki:V|'''V''']] [[LncRNAWiki:W|'''W''']] [[LncRNAWiki:X|'''X''']] [[LncRNAWiki:Y|'''Y''']] [[LncRNAWiki:Z|'''Z''']] [[LncRNAWiki:Featured|'''BACK''']] | ||
| + | </div> | ||
| + | |||
{|class="wikitable sortable" style="width:90%;text-align:center" | {|class="wikitable sortable" style="width:90%;text-align:center" | ||
|- | |- | ||
| Line 5: | Line 9: | ||
!Alias | !Alias | ||
!Description | !Description | ||
| + | !Disease | ||
|- | |- | ||
|''EGFR-AS1'' | |''EGFR-AS1'' | ||
| Line 10: | Line 15: | ||
|N/A | |N/A | ||
|EGFR antisense RNA 1 | |EGFR antisense RNA 1 | ||
| + | |_ | ||
|- | |- | ||
|''EGOT'' | |''EGOT'' | ||
|[[NONHSAT087635]] | |[[NONHSAT087635]] | ||
| − | |EGO, eosinophil granule ontogeny, NCRNA00190, non-protein coding RNA 190, ENSG00000235947 | + | |"EGO, ""eosinophil granule ontogeny"", NCRNA00190, ""non-protein coding RNA 190"", ENSG00000235947" |
|Eosinophil granule ontogeny (EGO) RNA | |Eosinophil granule ontogeny (EGO) RNA | ||
| + | |breast cancer | ||
|- | |- | ||
|''ELFN1-AS1'' | |''ELFN1-AS1'' | ||
| Line 20: | Line 27: | ||
|N/A | |N/A | ||
|ELFN1 antisense RNA 1 | |ELFN1 antisense RNA 1 | ||
| + | |_ | ||
|- | |- | ||
|''EMX2OS'' | |''EMX2OS'' | ||
|[[lnc-PDZD8-3:1]] | |[[lnc-PDZD8-3:1]] | ||
| − | |EMX2-AS1, NCRNA00045, non-protein coding RNA 45,ENSG00000229847 | + | |"EMX2-AS1, NCRNA00045, ""non-protein coding RNA 45"",ENSG00000229847" |
|Emx2 opposite strand transcript. | |Emx2 opposite strand transcript. | ||
| + | |_ | ||
|- | |- | ||
|''ENTPD3-AS1'' | |''ENTPD3-AS1'' | ||
| Line 30: | Line 39: | ||
|FLJ36665 | |FLJ36665 | ||
|ENTPD3 antisense RNA 1 | |ENTPD3 antisense RNA 1 | ||
| + | |_ | ||
|- | |- | ||
|''EPB41L4A-AS1'' | |''EPB41L4A-AS1'' | ||
| Line 35: | Line 45: | ||
|TIGA1 | |TIGA1 | ||
|EPB41L4A antisense RNA 1 | |EPB41L4A antisense RNA 1 | ||
| + | |cancer | ||
|- | |- | ||
|''EPB41L4A-AS2'' | |''EPB41L4A-AS2'' | ||
| Line 40: | Line 51: | ||
|FLJ11235 | |FLJ11235 | ||
|EPB41L4A antisense RNA 2 (head to head) | |EPB41L4A antisense RNA 2 (head to head) | ||
| + | |_ | ||
|- | |- | ||
|''ERC2-IT1'' | |''ERC2-IT1'' | ||
| Line 45: | Line 57: | ||
|Po42 | |Po42 | ||
|ERC2 intronic transcript 1 | |ERC2 intronic transcript 1 | ||
| + | |_ | ||
|- | |- | ||
|''ERICD'' | |''ERICD'' | ||
|[[Lnc-CHRAC1-2:1]] | |[[Lnc-CHRAC1-2:1]] | ||
| − | |TCONS_00014875, ERIC | + | |"TCONS_00014875, ERIC" |
|E2F1-regulated inhibitor of cell death (non-protein coding) | |E2F1-regulated inhibitor of cell death (non-protein coding) | ||
| + | |_ | ||
|- | |- | ||
|''ERICH1-AS1'' | |''ERICH1-AS1'' | ||
| Line 55: | Line 69: | ||
|N/A | |N/A | ||
|ERICH1 antisense RNA 1 | |ERICH1 antisense RNA 1 | ||
| + | |_ | ||
|- | |- | ||
|''ESRG'' | |''ESRG'' | ||
| Line 60: | Line 75: | ||
|HESRG | |HESRG | ||
|embryonic stem cell related (non-protein coding) | |embryonic stem cell related (non-protein coding) | ||
| + | |embryonal carcinoma, intracranial aneurism | ||
|- | |- | ||
|''Evf2'' | |''Evf2'' | ||
|[[lnc-DLX5-3:1]] | |[[lnc-DLX5-3:1]] | ||
| − | |Evf-2, Dlx6as1, Dlx6os1, ENSG00000231764 | + | |"Evf-2, Dlx6as1, Dlx6os1, ENSG00000231764" |
| − | | | + | |_ |
| + | |_ | ||
|- | |- | ||
|''EWSAT1'' | |''EWSAT1'' | ||
| Line 70: | Line 87: | ||
|FLJ33768 | |FLJ33768 | ||
|Ewing sarcoma associated transcript 1 | |Ewing sarcoma associated transcript 1 | ||
| + | |Ewing sarcoma | ||
|- | |- | ||
|''EXOC3-AS1'' | |''EXOC3-AS1'' | ||
| Line 75: | Line 93: | ||
|N/A | |N/A | ||
|EXOC3 antisense RNA 1 | |EXOC3 antisense RNA 1 | ||
| + | |_ | ||
|- | |- | ||
|''EXTL3-AS1'' | |''EXTL3-AS1'' | ||
| Line 80: | Line 99: | ||
|N/A | |N/A | ||
|EXTL3 antisense RNA 1 | |EXTL3 antisense RNA 1 | ||
| + | |_ | ||
|} | |} | ||
Revision as of 10:12, 30 June 2016
| Name | Transcript ID | Alias | Description | Disease |
|---|---|---|---|---|
| EGFR-AS1 | EGFR-AS1 | N/A | EGFR antisense RNA 1 | _ |
| EGOT | NONHSAT087635 | "EGO, ""eosinophil granule ontogeny"", NCRNA00190, ""non-protein coding RNA 190"", ENSG00000235947" | Eosinophil granule ontogeny (EGO) RNA | breast cancer |
| ELFN1-AS1 | ELFN1-AS1 | N/A | ELFN1 antisense RNA 1 | _ |
| EMX2OS | lnc-PDZD8-3:1 | "EMX2-AS1, NCRNA00045, ""non-protein coding RNA 45"",ENSG00000229847" | Emx2 opposite strand transcript. | _ |
| ENTPD3-AS1 | ENTPD3-AS1 | FLJ36665 | ENTPD3 antisense RNA 1 | _ |
| EPB41L4A-AS1 | EPB41L4A-AS1 | TIGA1 | EPB41L4A antisense RNA 1 | cancer |
| EPB41L4A-AS2 | EPB41L4A-AS2 | FLJ11235 | EPB41L4A antisense RNA 2 (head to head) | _ |
| ERC2-IT1 | ERC2-IT1 | Po42 | ERC2 intronic transcript 1 | _ |
| ERICD | Lnc-CHRAC1-2:1 | "TCONS_00014875, ERIC" | E2F1-regulated inhibitor of cell death (non-protein coding) | _ |
| ERICH1-AS1 | ERICH1-AS1 | N/A | ERICH1 antisense RNA 1 | _ |
| ESRG | ENST00000583516.1 | HESRG | embryonic stem cell related (non-protein coding) | embryonal carcinoma, intracranial aneurism |
| Evf2 | lnc-DLX5-3:1 | "Evf-2, Dlx6as1, Dlx6os1, ENSG00000231764" | _ | _ |
| EWSAT1 | EWSAT1 | FLJ33768 | Ewing sarcoma associated transcript 1 | Ewing sarcoma |
| EXOC3-AS1 | EXOC3-AS1 | N/A | EXOC3 antisense RNA 1 | _ |
| EXTL3-AS1 | EXTL3-AS1 | N/A | EXTL3 antisense RNA 1 | _ |
